ctrl K

Watchlist Price Alert

Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · Real-Time Price · USD

1.42

-0.04 (-2.74%)

At close: Jun 16, 2025, 3:59 PM

1.45

2.11%

Pre-market: Jun 17, 2025, 09:15 AM EDT

Cardiol Therapeutics Income Statement

Financials in CAD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	78.76K	n/a	n/a	n/a	n/a
Cost of Revenue	248.35K	219.91K	n/a	229.54K	150.57K	91.49K	53.34K
Gross Profit	-248.35K	-219.91K	78.76K	-229.54K	-150.57K	-91.49K	-53.34K
Operating Income	-29.79M	-50.34M	-45.47M	-20.61M	-13.58M	-7.39M	-1.59M
Interest Income	2.04K	1.24M	106K	76.58K	245.42K	103.31K	6.12K
Pretax Income	-28.13M	-30.93M	-31.64M	-20.64M	-13.68M	-15.89M	-1.66M
Net Income	-28.13M	-30.93M	-31.64M	-20.64M	-13.68M	-15.89M	-1.66M
Selling & General & Admin	15.56M	22.37M	27.87M	9.95M	10.45M	5.87M	1.1M
Research & Development	14.22M	18.96M	10.87M	10.52M	3.53M	1.53M	441.26K
Other Expenses	0.00	164.44K	112.23K	7.4K	298.8K	n/a	-60.56K
Operating Expenses	29.79M	41.34M	38.74M	20.69M	14.13M	7.49M	1.6M
Interest Expense	n/a	n/a	n/a	n/a	621.00	663.37K	60.56K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	29.79M	41.34M	38.74M	20.69M	14.13M	7.49M	1.6M
Income Tax Expense	n/a	-10.24M	-6.91M	7.4K	299.42K	663.37K	60.56K
Shares Outstanding (Basic)	64.46M	62.51M	43.22M	29.86M	25.82M	15.37M	22.71M
Shares Outstanding (Diluted)	64.46M	62.51M	43.22M	29.86M	25.82M	15.37M	22.71M
EPS (Basic)	-0.44	-0.49	-0.73	-0.69	-0.53	-1.03	-0.07
EPS (Diluted)	-0.44	-0.49	-0.73	-0.69	-0.53	-1.03	-0.07
EBITDA	-29.59M	-41.16M	-38.44M	-20.46M	-11.77M	-7.3M	-1.5M
EBIT	-29.79M	-41.34M	-38.66M	-20.69M	-11.89M	-6.58M	-1.56M
Depreciation & Amortization	195.26K	219.91K	220.42K	229.54K	150.57K	91.49K	53.34K